Dec 05,2023

PCMIS Health Technologies Contracted to Support Silvercloud® By Amwell® Delivery of National Digital Mental Health Program for Ireland

PCMIS Health Technologies’ patient record system will provide effective, evidence-based case and risk management and outcome monitoring through a seamless integration with SilverCloud by Amwell. In addition, PCMIS will facilitate comprehensive national reporting as part of the next phase of the SilverCloud and Ireland Health Service Executive (HSE) partnership. PCMIS and Amwell have a history of collaboration and integration, having been the first to offer a “Digital First” referral and treatment pathway for NHS England Talking Therapies services in 2019. This is the first time the companies have worked together on a national health programme and as such, marks a new phase in their integrated approach to deliver tech solutions that drive service efficiencies and improve treatment outcomes. “The SilverCloud platform has seen a significant increase in use since working with the HSE. Our ongoing collaboration with PCMIS will play a key role in maintaining the efficient delivery of services on the platform through this growth." said Elaine Martin, Director of SilverCloud Clinical Operations at Amwell.

COLLABORATION PARTNERSHIP

#institution

#cbt

View Analyst & Ambassador Comments
Go to original news
Dec 07,2023 TOP STORY

Feel Therapeutics Announces Study Results of their Proprietary Digital Precision Medicine Platform, Validating Promising Impact on Mental Health Conditions

Feel Therapeutics recently announced the results of a study on their platform offered as a digital mental health support program for depression and anxiety in populations with ADHD. Feel Therapeutics, building on the success of their previous study, has demonstrated that their Digital Precision Medicine Platform not only improves outcomes in depression and anxiety (MDD/GAD) but also extends its benefits to address chronic conditions. The real-world data, single-arm study included 30 adult participants with ADHD symptomatology and coexisting depressive or anxiety symptoms who joined a 16-week digital, data-driven mental health support program. The targeted symptomatology was evaluated using the Patient Health Questionnaire–9, Generalized Anxiety Disorder–7, and Barkley Adult ADHD Rating Scale–IV. An average decrease of 46.2% in depressive symptoms and 46.4% in anxiety symptoms was observed, with clinically significant improvement for more than half of the participants. The findings support the feasibility, acceptability, and value of the examined digital program for adults with ADHD symptomatology to address the coexisting depressive or anxiety symptoms.

CLINCIAL STUDY

#connected device

#mobile app

View Analyst & Ambassador Comments
Go to original news
Nov 15,2023

DTx Commercialization Launch Playbook Case Study from Freespira

DTx Alliance has shared a recent white paper focusing the on the case study with Freespira including ClearView Healthcare Partners' advisory services, exploring the critical success factors that drive a successful launch in the Digital Therapeutics (DTx) landscape. Learnings from Freespira’s launch, along with ClearView’s broader experience in supporting DTx companies, illuminate the importance of patient journey mapping, defining the end customer, and market shaping for a successful launch.

View Analyst & Ambassador Comments
Go to original news
Oct 26,2023 TOP STORY

First Randomized Controlled Trial Comparing Woebot to Clinician-Led Psychotherapy Reveals Digital Mental Health Intervention is Non-Inferior in Reducing Depressive Symptoms Among Teens

Woebot Health announced positive results from a study at Children’s Hospital of The King’s Daughters (CHKD) showing that the digital mental health intervention W-GenZD, a Woebot-based study app, led to reductions in depressive symptoms that were non-inferior to those achieved by a clinician-led telehealth Cognitive Behavioral Therapy (CBT) skills group. The study was designed to investigate the feasibility, satisfaction and non-inferiority (for PHQ-8) of W-GenZD (n = 71) compared to a group receiving CBT skills delivered via telehealth and led by a licensed mental health clinician (n = 70). Participants in both the W-GenZD and telehealth groups reported a significant reduction in depressive symptoms (PHQ-8) from baseline to end of treatment (week 4) and had similar levels of intervention feasibility and satisfaction. The results were presented in a poster presentation at the American Academy of Child and Adolescent Psychiatry (AACAP) conference.

CLINICAL STUDY

#mobile app

#chatbot

View Analyst & Ambassador Comments
Go to original news
Oct 24,2023 TOP STORY

HSE Shows Strong Mental Health Patient Outcomes Using Silvercloud® By Amwell® Digital Programmes

The Health Service Executive (HSE) shared a new report highlighting a key milestone in the technology partnership with SilverCloud® by Amwell®; more than 12,300 people have used the SilverCloud platform’s guided digital Cognitive Behaviour Therapy (iCBT) programmes, as of August 2023. The report, which follows November’s research report on the first 5,000 users to utilise the programmes, details the continued progress of the HSE partnership, and outlines the encouraging clinical success, uptake and effectiveness of the platform. 49% of users with clinical levels of depression showed clinically meaningful improvement and 59% of users with clinical levels of anxiety showed clinically meaningful improvement.

COLLABORATION PARTNERSHIP

#institution

#cbt

#mobile app

View Analyst & Ambassador Comments
Go to original news
Oct 05,2023

An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia

Click Therapeutics, and Boehringer Ingelheim as the collaborator, registered an open label extension, randomized phase 3 trial to evaluate the maintained efficacy and safety of a second consecutive course of Click Therapeutics Study App as an adjunct treatment to standard of care (SOC) in participants who were on the Study App and have recently completed the Click Therapeutics Randomized Clinical Trial NCT05853900. The study aims to enroll 216 late adolescents and adults who completed participation in NCT05853900 (Week 20) study within 7 days of the extension study Baseline Visit (Day 1). The primary outcome measure is the change from baseline to Week 16 in the Clinical Assessment Interview for Negative Symptoms, Motivation and Pleasure Scale (CAINS-MAP).

CLINICAL STUDY

#pdt

View Analyst & Ambassador Comments
Go to original news
Oct 18,2023 TOP STORY

Noom Announces Navitus Health Solutions as Latest Noom for Work Partner

Noom announced that its enterprise unit, Noom for Work, has entered into a partnership with Navitus Health Solutions, LLC, a unique pass-through pharmacy benefit manager (PBM), to help its clients and members gain better physical and mental health outcomes through Noom Weight, Noom Diabetes Prevention Program, and Noom Mood. These programs are also available for clients of EpiphanyRx, Navitus’ in-house solution for emerging market employers. As employers and payers are continually looking for opportunities to drive efficiencies, uncover cost savings, and bring cutting-edge programs to their clients and members, Noom for Work provides an all-in-one platform that meets these needs.

COLLABORATION PARTNERSHIP

#institution

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
Oct 18,2023 TOP STORY

Virtua Health Signs With Woebot Health To Deliver Adjunctive Mental Health Tool To Patients

Virtua Health and Woebot Health today announced a collaboration that allows Virtua Health primary care clinicians and specialists to provide Woebot for Adults as a clinically directed adjunctive tool for people waiting to see a behavioral health provider or seeking support outside of traditional in-person therapy sessions. As part of the collaboration, the Virtua Health team will work with Woebot Health to implement a shared resource center providing the training, deployment and reporting resources to seamlessly deliver Woebot for Adults within the organization’s clinical care pathway. The collaboration will also add to the industry’s understanding of the benefits of digital therapeutics by assessing aggregate patient outcomes, healthcare resource utilization and health economics results. The organizations are kicking off their collaboration in advance of the typically stress-filled holiday season, and expect to expand it in the future. Financial terms were not disclosed.

COLLABORATION PARTNERSHIP

#institution

#mobile app

#chatbot

View Analyst & Ambassador Comments
Go to original news
Oct 18,2023

Point32Health Announces Three Finalists in Second Annual Innovation Challenge

Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, has announced three finalists for its second annual Innovation Challenge this fall: Cognoa, based in Palo Alto, California, developed Canvas Dx, the first-and-only FDA-authorized autism diagnostic for children starting at 18 months; Curio Digital Therapeutics, based in Princeton, NJ, developer of Curio-I™ that is an AI-Analytics tool that predicts/stratifies pregnant women pre-delivery/third trimester at risk for depression; and finally Movn Health, based in Irvine, California, a leading telehealth provider. The Innovation Challenge is an opportunity for one or more of these companies to work with Point32Health on a pilot or program, funded by the insurer.

View Analyst & Ambassador Comments
Go to original news
Oct 18,2023 TOP STORY

Noom Announces Navitus Health Solutions as Latest Noom for Work Partner

Noom announced that its enterprise unit, Noom for Work, has entered into a partnership with Navitus Health Solutions, LLC, a unique pass-through pharmacy benefit manager (PBM), to help its clients and members gain better physical and mental health outcomes through Noom Weight, Noom Diabetes Prevention Program, and Noom Mood. These programs are also available for clients of EpiphanyRx, Navitus’ in-house solution for emerging market employers. As employers and payers are continually looking for opportunities to drive efficiencies, uncover cost savings, and bring cutting-edge programs to their clients and members, Noom for Work provides an all-in-one platform that meets these needs.

COLLABORATION PARTNERSHIP

#institution

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
Subscribe to MENTAL HEALTH